Biohit Oyj B Stock Short Ratio
BIOBV Stock | EUR 2.29 0.03 1.33% |
Biohit Oyj B fundamentals help investors to digest information that contributes to Biohit Oyj's financial success or failures. It also enables traders to predict the movement of Biohit Stock. The fundamental analysis module provides a way to measure Biohit Oyj's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biohit Oyj stock.
Biohit |
Biohit Oyj B Company Short Ratio Analysis
Biohit Oyj's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Competition |
Based on the latest financial disclosure, Biohit Oyj B has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The short ratio for all Finland stocks is 100.0% higher than that of the company.
Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
All Next | Launch Module |
Biohit Fundamentals
Return On Equity | 0.0645 | |||
Return On Asset | 0.0652 | |||
Profit Margin | 0.04 % | |||
Operating Margin | 0.1 % | |||
Current Valuation | 20.88 M | |||
Shares Outstanding | 12.07 M | |||
Shares Owned By Insiders | 47.13 % | |||
Price To Earning | 11.00 X | |||
Price To Book | 3.28 X | |||
Price To Sales | 2.16 X | |||
Revenue | 9.36 M | |||
Gross Profit | 5.92 M | |||
EBITDA | 693 K | |||
Net Income | (1.5 M) | |||
Cash And Equivalents | 9.38 M | |||
Cash Per Share | 0.63 X | |||
Total Debt | 59 K | |||
Debt To Equity | 0.30 % | |||
Current Ratio | 7.79 X | |||
Book Value Per Share | 0.53 X | |||
Cash Flow From Operations | (444 K) | |||
Earnings Per Share | 0.03 X | |||
Target Price | 3.8 | |||
Number Of Employees | 44 | |||
Beta | 1.02 | |||
Market Capitalization | 30.69 M | |||
Total Asset | 9.61 M | |||
Retained Earnings | 6 M | |||
Working Capital | 8 M | |||
Current Asset | 9 M | |||
Current Liabilities | 1000 K | |||
Net Asset | 9.61 M |
About Biohit Oyj Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biohit Oyj B's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biohit Oyj using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biohit Oyj B based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Biohit Stock
Biohit Oyj financial ratios help investors to determine whether Biohit Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biohit with respect to the benefits of owning Biohit Oyj security.